IL137304A - Expanded and genetically modified populations of human hematopoietic stem cells - Google Patents

Expanded and genetically modified populations of human hematopoietic stem cells

Info

Publication number
IL137304A
IL137304A IL13730499A IL13730499A IL137304A IL 137304 A IL137304 A IL 137304A IL 13730499 A IL13730499 A IL 13730499A IL 13730499 A IL13730499 A IL 13730499A IL 137304 A IL137304 A IL 137304A
Authority
IL
Israel
Prior art keywords
stem cells
hematopoietic stem
expanded
genetically modified
human hematopoietic
Prior art date
Application number
IL13730499A
Other languages
English (en)
Other versions
IL137304A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/237,291 external-priority patent/US20030044978A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL137304A0 publication Critical patent/IL137304A0/xx
Publication of IL137304A publication Critical patent/IL137304A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13730499A 1998-02-05 1999-01-29 Expanded and genetically modified populations of human hematopoietic stem cells IL137304A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1942898A 1998-02-05 1998-02-05
US7683698P 1998-03-04 1998-03-04
US09/237,291 US20030044978A1 (en) 1998-02-05 1999-01-25 Expanded and genetically modified populations of human hematopoietic stem cells
PCT/EP1999/000597 WO1999040180A2 (en) 1998-02-05 1999-01-29 Expanded and genetically modified populations of human hematopoietic stem cells

Publications (2)

Publication Number Publication Date
IL137304A0 IL137304A0 (en) 2001-07-24
IL137304A true IL137304A (en) 2005-09-25

Family

ID=27361219

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13730499A IL137304A (en) 1998-02-05 1999-01-29 Expanded and genetically modified populations of human hematopoietic stem cells

Country Status (10)

Country Link
EP (1) EP1053302B1 (de)
JP (1) JP2002502599A (de)
AT (1) ATE314461T1 (de)
AU (1) AU755344B2 (de)
CA (1) CA2318819A1 (de)
DE (1) DE69929174T2 (de)
ES (1) ES2252932T3 (de)
IL (1) IL137304A (de)
NZ (2) NZ505997A (de)
WO (1) WO1999040180A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7547674B2 (en) * 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7862810B2 (en) 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
AU2001284695A1 (en) 2000-07-31 2002-02-13 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
AU2001294577A1 (en) * 2000-09-21 2002-04-02 Schering Corporation Methods for preparing interferon producing dentitric cells
US20060153813A1 (en) * 2003-07-06 2006-07-13 Quesenberry Peter J Methods of producing differentiated hematopoietic cells for treatment of cytopenia
GB0329449D0 (en) * 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
EP1773981A1 (de) * 2004-07-12 2007-04-18 Sorin Group Italia S.R.L. Vorrichtung und verfahren zur anzucht menschlicher zellen
ES2538305T3 (es) 2004-10-25 2015-06-18 Cellerant Therapeutics, Inc. Métodos para expandir poblaciones de células mieloides y usos de las mismas
JP5341525B2 (ja) 2006-02-14 2013-11-13 セルラント セラピューティクス，インコーポレイティド 造血幹細胞の生着を増強するための方法および組成物
US9115341B2 (en) 2007-12-05 2015-08-25 Nissan Chemical Industries, Ltd. Method for expanding hematopoietic stem cells using heterocyclic compound
JP5573160B2 (ja) * 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
WO2009072624A1 (ja) * 2007-12-05 2009-06-11 Nissan Chemical Industries, Ltd. ヘテロ環化合物による造血幹細胞の増幅方法
GB0818725D0 (en) 2008-10-13 2008-11-19 Habib Nagy A Pharmaceutical composition
ES2336637B1 (es) * 2009-11-02 2011-01-21 Banc De Sang I Teixits Procedimiento parala expansion indiferenciada u orientada a linaje mieloide de celulas madre hematopoyeticas procedentes de sangre de cordonumbilical, sangre periferica movilizada o medula osea.
DK3194602T3 (da) * 2014-09-18 2020-02-17 Univ Montreal Forbindelser og fremgangsmåder til at forstærke virusgenoverførsel til humane hæmatopoietiske celler

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314644A (en) * 1993-05-24 2000-11-24 Immunex Corp Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
US6060052A (en) * 1995-10-30 2000-05-09 Systemix, Inc. Methods for use of Mpl ligands with primitive human hematopoietic stem cells

Also Published As

Publication number Publication date
EP1053302B1 (de) 2005-12-28
AU755344B2 (en) 2002-12-12
IL137304A0 (en) 2001-07-24
WO1999040180A3 (en) 1999-10-28
ATE314461T1 (de) 2006-01-15
WO1999040180A2 (en) 1999-08-12
WO1999040180A9 (en) 1999-11-25
AU2721299A (en) 1999-08-23
DE69929174D1 (de) 2006-02-02
JP2002502599A (ja) 2002-01-29
ES2252932T3 (es) 2006-05-16
DE69929174T2 (de) 2006-08-31
CA2318819A1 (en) 1999-08-12
NZ505997A (en) 2003-08-29
NZ524254A (en) 2004-11-26
EP1053302A2 (de) 2000-11-22

Similar Documents

Publication Publication Date Title
IL137304A0 (en) Expanded and genetically modified populations of human hematopoietic stem cells
Stewart et al. Studies on the spores of aerobic bacteria I: The occurrence of alanine racemase
CA2407505A1 (en) Hepatocyte lineage cells derived from pluripotent stem cells
HU197766B (en) Process for producing cell lines independent of serum
JP2003513664A5 (de)
CA2388811A1 (en) Techniques for growth and differentiation of human pluripotent stem cells
ATE296875T1 (de) Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen
ATE399855T1 (de) Tierzellkulturmedium mit pflanzlichen nährstoffen
EP2221361A3 (de) Methode zur Herstellung eines Polypeptids in vitro in einer Säugerzelle in einem Kulturmedium ohne Serum und ohne Proteine
BR0008772B1 (pt) vetor de expressão, célula bacteriana ou fúngica cultivada, processos para expandir in vitro células hematopoiéticas e progenitores de células hematopoiéticas, e para detectar a presença de rna de ligando zalfa11 e de ligando zalfa 11 in vitro em uma amostra biológica.
KR950700403A (ko) 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering)
NZ502712A (en) Medium and method for long term culturing of avian primordial germ cells (PGC) in a tissue culture comprising growth factors
EP1736536A3 (de) Zellkulturspinnerflaschen
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
ES8301503A1 (es) Procedimiento para la produccion de un microorganismo gene- ticamente modificado
EP2281892A3 (de) Verfahren zur Herstellung von Polypeptiden in atmungsdefizienten Trichoderma Zellen
CN109486759A (zh) 一种脐带血nk细胞的培养方法
AU4816201A (en) Production of tcr gamma delta t cells
EP1270719A3 (de) Hemangioblasten enthaltender Zellverband und dessen Herstellungsverfahren
Bogenmann et al. Invasive properties of primary pediatric neoplasms in vitro
Sanford et al. Serum-induced chromosome damage and neoplastic transformation of mouse cells in vitro
URAKAMI et al. Characterization and identification of methanol-utilizing Hyphomicrobium strains and a comparison with species of Hyphomonas and Rhodomicrobium
Rubin et al. Inheritance of acquired changes in growth capacity of spontaneously transformed BALB/3T3 cells propagated in mice and in culture
Eaves et al. Culture purging in leukemia: past, present, and future
EP0927043B8 (de) Zusammensetzungen zur gentransfer in das zentrale nervensystem

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees